XML 84 R73.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Identifiable Intangible Assets and Goodwill - Goodwill (Detail)
$ in Millions
6 Months Ended
Jun. 30, 2024
USD ($)
[1]
Goodwill [Roll Forward]  
Balance, January 1, 2024 $ 67,783
Additions 677 [2]
Impact of foreign exchange (16)
Balance, June 30, 2024 $ 68,445
[1] All goodwill is assigned within the Biopharma reportable segment. As a result of the organizational changes to the commercial structure within the Biopharma operating segment effective in the first quarter of 2024 (see Note 13A), our goodwill is required to be reallocated amongst impacted reporting units. The allocation of goodwill is a complex process that requires, among other things, that we determine the fair value of each reporting unit under our old and new organizational structure and the portions being transferred. Therefore, we have not yet completed the allocation, but it will be completed in the current year.
[2] Additions primarily represent measurement period adjustments related to our acquisition of Seagen (see Note 2A).